Peptides versus Nonpeptides as Therapeutics: An Exciting Challenge for Big Pharma

被引：0

|

作者：

Manning, M. ^{[1
]}

Stoev, S. ^{[1
]}

Bankowski, K. ^{[1
]}

机构：

[1] Univ Toledo, Coll Med, Toledo, OH 43606 USA

来源：

JOURNAL OF PEPTIDE SCIENCE | 2010年 / 16卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：136 / 136

页数：1

相关论文

共 6 条

[1] BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management
Rodwin, Victor G.
Fabre, Guilhem
Ayoub, Rafael F.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2018, 7 (03) : 201 - 206
[2] Improving patient safety in critical care: big challenge, exciting opportunity
Dodek, P
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2005, 52 (05): : 459 - 462
[3] A better fit? Biotech versus Big Pharma in orphan/rare disease drug research
O'Neil, Deborah A.
EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (04): : 317 - 319
[4] The big and small of drug discovery - Biotech versus pharma: advantages and drawbacks in drug development
Moore, A
EMBO REPORTS, 2003, 4 (02) : 114 - 117
[5] Very Large Pores Mesoporous Silica as New Candidate for Delivery of Big Therapeutics Molecules, Such as Pharmaceutical Peptides
Carrozza, Debora
Malavasi, Gianluca
Ferrari, Erika
MATERIALS, 2023, 16 (11)
[6] Improving patient safety in critical care: big challenge, exciting opportunityL’amélioration de la sécurité des patients à l’unité des soins intensifs : Un grand défi, une occasion stimulante
Peter Dodek
Canadian Journal of Anesthesia, 2005, 52 (5): : 459 - 462